Caffeine gives a small boost to painkillers' effectiveness

March 16, 2012 By Christen Brownlee

Caffeine improves the effectiveness of over-the-counter pain relieving drugs, but only by a small margin, according to a new evidence review in The Cochrane Library.

Caffeine, the same stimulant present in coffee, tea, , and , is a common ingredient in many sold in the . However, adding to analgesics was based on scant evidence from studies conducted nearly 30 years ago , said review author Sheena Derry, a senior research officer at University of Oxford in the U.K.  Previous studies have shown that caffeine has no significant effect in reducing .

“Caffeine has been added to a large number of analgesic formulations based on this ‘inherited wisdom,’ but uncertainty has remained and arguments persist” as to its effectiveness, she said.

To settle the debate, Derry and her colleagues collected evidence from modern, randomized, double-blind studies that compared patients who received a dose of analgesic to those who received the same dose plus a standard amount of caffeine.  19 studies together evaluated 7,238 patients who took mostly acetaminophen or ibuprofen, some with 100 to 130 mg of added caffeine. The patients took these drugs for a variety of painful conditions, including post-surgical dental pain, postpartum pain, and headache.

Combined results from all the studies showed that the groups of patients randomized to take pain medicine that included caffeine had a significantly larger proportion of individuals who had a good level of pain relief. Specifically, an additional five to 10 percent of patients who took the caffeinated formulations said that they experienced at least 50 percent of the maximum possible pain relief over four to six hours, considered their treatment very good or excellent, or had headache relief after two hours.

Derry says that the mechanism by which caffeine boosts other painkillers’ effectiveness is currently unknown. The could have multiple effects, including getting other drugs into the bloodstream faster, raising their concentration by slowing their clearance from the bloodstream, directly affecting how nerves perceive pain, or even changing how people perceive pain by affecting their moods or emotions.

Regardless, she added, the boost in analgesic effectiveness could be a boon for patients. “Although the size of the effect is small, it is probably clinically useful,” Derry said.

According to Steven P. Cohen, M.D., associate professor of anesthesiology and critical care medicine at the Johns Hopkins School of Medicine and director of pain research at Walter Reed National Military Medical Center, doctors should choose carefully which patients receive caffeine along with their regular pain medicines. Since the booster effect is small, he explains, patients taking strong painkillers for very painful conditions probably won’t benefit.

However, he says, the is a relatively harmless addition that might help patients with more minor conditions.

“Caffeine is a really, really safe drug, so safe that we don’t regulate it,” he says. “Basically, it’s a very minimal risk and might be beneficial, depending on the patient.”

Explore further: Caffeine can ease a spinal tap headache

More information: Derry, C.J., et al. (2012). Caffeine as an analgesic adjuvant for acute pain in adults. The Cochrane Library, DOI: 10.1002/14651858.CD009281.pub2

Related Stories

Caffeine can ease a spinal tap headache

August 10, 2011
People who suffer headaches after a spinal tap might have a relatively simple way to ease the painful throb: a caffeine tablet.

Pain relief can now be based on solid evidence

September 7, 2011
A Cochrane Review of data relating to about 45,000 patients involved in approximately 350 individual studies has provided an evaluation of the effect you can expect to get if you take commonly used painkillers at specific ...

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.